Wave Life Sciences, Inc. (WVE) Gets $12M As GSK Selects Hepatology siRNA

Wave Life Sciences will receive a $12M milestone after GSK selected a hepatology GalNAc-siRNA candidate from their collaboration; three additional programs are advancing toward candidate selection.Material DetailsContext by AI AnalystThis is an early-to-mid validation milestone within Wave’s partne…